Characteristics of a prospective cohort of short-term travelers from the Netherlands who visited a malaria-endemic area, October 2006–October 2007.

<p>Characteristics of a prospective cohort of short-term travelers from the Netherlands who visited a malaria-endemic area, October 2006–October 2007.</p

Adherence to the most-prescribed antimalarial chemoprophylaxis among travelers who started with recommended chemoprophylaxis.

<p>NA, not applicable.</p

Characteristics and symptoms of subjects with anti-circumsporozoite antibody seroconversion for <i>P. falciparum</i>, from a cohort of 945 travelers from the Netherlands who visited malaria-endemic areas, October 2006–October 2007.

b<p>DEET (N,N-diethyl-meta-toluamide) use in more than the mean use in the study population.</p

Determinants for 75% adherence to malaria chemoprophylaxis during travel among a prospective cohort of 620 travelers from the Netherlands to high-endemic areas, October 2006–October 2007.

b<p>In the multivariable analysis the variable ‘type of chemoprophylaxis’ was included without the category ‘other’ because of 100% compliance, so multivariable analysis was done with 610 travelers.</p

Routing and quality of service in wireless and disruption tolerant networks

Wireless networks have become a common means of communication, and their popularity continues to rise as they enable communication in locations and settings where it was previously unfeasible. While promising many advantages, these networks also pose new challenges. The limited radio coverage, unreliable nature of the wireless channel, and mobility of network nodes can lead to frequent disruption of communication links, dynamic network topology, variable bandwidth availability, and high channel error rates. These challenges seek novel solutions to allow a growing number of wireless, mobile users to run applications and avail network services in ways similar to that in wired networks. This thesis makes contributions to three research areas related to wireless and disruption tolerant networks: (1) routing and forwarding to enable disruption tolerant communication in intermittently connected networks, (2) analysis of properties of human mobility and their effect on network protocols in disruption tolerant networks, and (3) quality of service mechanisms for wireless and mobile networks. In intermittently connected networks, there may rarely or never exist a fully connected path between a source and destination. This invalidates the basic assumption of end-to-end communication prevalent in the Internet and renders traditional routing protocols impractical. We propose PRoPHET, a novel routing protocol for intermittently connected networks. PRoPHET takes advantage of the mobility of nodes, and the predictability of that mobility for routing. The protocol and various forwarding strategies and queueing policies are studied in detail. The benefits of PRoPHET are evident on comparing its performance with contemporary work. Communication in intermittently connected and disruption tolerant networks is often highly dependent on the mobility of the nodes in the network. Thus, it is important to have good understanding of basic properties of user mobility in order to design network protocols that can operate under those conditions. Using real-life traces, we characterize human mobility patterns and their impact on forwarding algorithms in mobile networks with and without infrastructure. Finally, the thesis presents our work on two different aspects of quality of service in wireless and mobile networks. We evaluate four mechanisms for providing service differentiation in a wireless LAN, and give recommendations on their use in different scenarios. We propose a novel admission control scheme for mobile ad hoc networks, which is able to better cope with high mobility in the network compared to previous solutions.Godkänd; 2006; 20061205 (haneit)</p

Genistein suppresses the early development of parasites within hepatocytes.

<p>(A) Hepa1-6 cells were incubated with genistein or DMSO and inoculated with 4×10⁴<i>P. berghei</i> ANKA sporozoites. The two images show EEFs observed 24 hours after infection of control (left) or genistein-treated cells (right) at a 1000× magnification. Bar = 2.5 μm. (B) Distribution of EEFs according to size. Hepa1-6 cells were treated with genistein or DMSO (control) immediately prior to inoculation with 4×10⁴<i>P. berghei</i> ANKA sporozoites and the size of 100 EEFs from different coverslips was determined 24 hours later. The figure shows the frequency of EEFs with sizes between 0 and 40 μm². ○ control; • 25 μM genistein. <i>P</i> = 5.9×10⁻²⁵ (TTest relative to the control group). The results are representative of 3 independent experiments. (C) Incubation of cultured HepG2 cells with 25 μM genistein or DMSO (control) at various times after addition of 4×10⁴<i>P. berghei</i> ANKA sporozoites. Infection was determined 24 hours after sporozoite addition by counting the total number of EEFs per coverslip. The results are expressed as the percentage of EEFs relative to the average number of EEFs in the control samples, taken as 100%. (D) Incubation of cultured HepG2 cells with 25 μM genistein or DMSO (control) at the time of addition of 4×10⁴<i>P. berghei</i> ANKA sporozoites and washed at various time-points. Infection was determined 24 hours after sporozoite addition by counting the total number of EEFs per coverslip. The results are expressed as the percentage of EEFs relative to the average number of EEFs in the control samples, taken as 100%. ★ p<0.05, ★★ p<0.01 ★★★ p<0.001 (TTest relative to control group). Bar plots show one representative of 3 independent experiments, error bars represent s.d. of mean number of EEFs in each condition (<i>n = </i>3). (E) Flow cytometry analysis of the invasion rate in genistein-treated and control Huh7 cells at 2 hours after addition of 3×10⁴ PbGFP sporozoites. Bar plots show one representative of 3 independent experiments, error bars represent s.d. of mean percentage of GFP positive cells in each condition (<i>n = </i>3). (F) Flow cytometry analysis of genistein-treated and control Huh7 cells at 6, 30 and 44 hours after addition of 3×10⁴ PbGFP sporozoites, and of primaquine-treated and control cells at 44 hours after adition of 3×10⁴ PbGFP sporozoites. Red line represents Genistein treated cells and black line represents control cells. The graphs show one representative dataset of triplicate samples. (G) Quantification of the GFP intensity of PbGFP-infected genistein-treated (red bars) and non-treated (black bars) cells at the same time points as in E. ★★ p<0.01 (TTest relative to control group). Bar plots show one representative of 3 independent experiments, error bars represent s.d. of mean GFP intensity in each condition (<i>n = </i>3).</p

Genistein inhibits <i>in vitro</i> hepatoma cell infection by <i>Plasmodium</i> sporozoites.

<p>Cultured Hepa1-6 cells were incubated with increasing doses of genistein (A) and cultured HepG2 and Huh7 cells were incubated with 25 μM of genistein (B) and (C). As control, cells were treated with equivalent volumes of DMSO as in the genistein treated groups. The number of infected cells was determined 24 hours after infection with 4×10⁴<i>P. berghei</i> ANKA sporozoites and is shown as the total number of EEFs in each coverslip. Each condition was assayed in duplicate in (A) or triplicate in (B) and (C). ★ p<0.05, ★★ p<0.01 (TTest relative to control group). Bar plot shows one representative of 3 independent experiments, error bars represent s.d. of mean number of EEFs in each condition. (D) Cultured HepG2 cells were incubated with different concentrations of genistein, or DMSO (control). After 24 hours the number of adherent cells in 10 microscope fields representing approximately 20% of the total area was assessed at 400× magnification. Each condition was assayed in duplicate. (E) Cultured Huh7 were incubated with Genstein or Taxol, along with their respective controls of DMSO, and allowed to grow for 24 hours. After this time both adherent and non-adherent cells were collected and incubated with propidium iodide. Percentage of death cells was quantified by flow cytometry. Bar plot shows one representative of 3 independent experiments, error bars represent s.d. of mean cell death percentage in each condition (n = 3). ★★ p<0.01 (TTest relative to control group). (F) <i>P. berghei</i> ANKA sporozoites were incubated with 100 μM genistein or DMSO for 30 min. Sporozoites were washed with PBS to remove genistein and used to infect cultured HepG2 cells. Infection was determined 24 hours post-infection by counting the total number of EEFs in each coverslip. Each experimental condition was assayed in triplicate. Bar plot shows one representative of 3 independent experiments. Error bars represent s.d. of mean number of EEFs in each condition (<i>n</i> = 3). (G) Huh7 cells were incubated with 25 μM genistein or DMSO for 2 h. Cells were then washed with PBS and fresh medium to remove genistein. P. berghei sporozoites were then added to these cells. Infection was determined 24 hours post-infection by counting the total number of EEFs in each coverslip. Each experimental condition was assayed in triplicate. Bar plot shows one representative of 3 independent experiments. Error bars represent s.d. of mean number of EEFs in each condition (<i>n</i> = 3).</p

Genistein partially protects from cerebral malaria.

<p>(A) Mice fed on a genistein-supplemented or control diet since breastfeeding were injected intravenously with <i>P. berghei</i> ANKA sporozoites (1×10⁴/mouse) and maintained for the analysis of blood infection. Peripheral blood parasitemia was determined, at different time points after infection, by counting the number of infected red blood cells in Giemsa stained thin blood films. ♦ control diet; ⋄ 1000 ppm genistein-supplemented diet, <i>n = 3</i> mice per group. ★ p<0.005 (TTest relative to control group). The results are representative of 3 independent experiments with a total of 15 control mice and 19 genistein-treated mice. (B) Same as in A between day 2 and day 8 after intravenous injection of <i>P. berghei</i> ANKA sporozoites by counting the number of infected red blood cells in Giemsa stained thin blood films. ♦ control diet; ⋄ 1000ppm genistein-supplemented diet, <i>n = </i>3 mice per group. (C) Cumulative survival of mice fed on a genistein-supplemented or control diet since breastfeeding when injected intravenously with <i>P. berghei</i> ANKA sporozoites (1×10⁴/mouse). Fifty-six percent of the mice fed on the genistein-supplementd diet and infected with <i>P. berghei</i> ANKA sporozoites are protected from developing cerebral malaria when compared with twenty percent of mice fed on the control diet. ♦ control diet, <i>n = </i>15; ⋄ 1000 ppm genistein supplemented diet, <i>n = </i>16. The gray area represents the time window for developing cerebral malaria in this model. <i>P</i> = 0.067 (Log-Rank Test). (D) Mice fed on a genistein-supplemented or control diet since breastfeeding were infected by intraperitoneal injection of 1×10⁶<i>P. berghei</i> ANKA iRBC. Peripheral blood parasitemia was determined throughout infection by counting the number of infected red blood cells in Giemsa stained thin blood films. Parasitemia indicates the percentage of iRBC in a given number of total red blood cells. ♦ control diet, <i>n = </i>6; ⋄ 1000 ppm genistein-supplemented diet, <i>n = </i>7. Results are representative of 2 independent experiments with a total of 11 control mice and 12 genistein-treated mice.</p

Effect of genistein on <i>Plasmodium</i> sporozoite-induced MET phoshorylation.

<p>Cultured Huh7 cells were treated with genistein or DMSO (control), and inoculated with 3×10⁴<i>P. berghei</i> ANKA sporozoites. Four hours later total protein extracts were analyzed with anti-phospho c-met (Tyr1234/1235) and MET antibodies. Quantification of intensity of each band was performed and plotted on a graph.</p

Genistein decreases mouse liver lnfection by <i>P. berghei</i> ANKA sporozoites.

<p>(A) Mice treated by intraperitoneal injection of 4 mg of genistein in a volume of 200μL DMSO, or with DMSO alone (control), were injected intravenously with <i>P. berghei</i> ANKA sporozoites (1×10⁴/mouse). Infection was determined 40 hours later by parasite-specific 18S rRNA qRT PCR (<i>n = </i>4 mice per group). ★ p<0.05 (TTest relative to control group). Bar plots show one representative of 3 independent experiments. Error bars represent s.d. of mean <i>P. berghei</i> ANKA 18S rRNA expression in each condition (<i>n = </i>3). (B) Mice treated by intraperitoneal injection of 4 mg of genistein in a volume of 200μL DMSO, or with DMSO alone (control), were injected intravenously with <i>P. yoelii</i> ANKA sporozoites (1×10⁴/mouse). Infection was determined 40 hours later by parasite-specific 18S rRNA qRT PCR (<i>n = </i>4 mice per group). ★ p<0.05 (TTest relative to control group). Bar plots show one representative of 3 independent experiments. Error bars represent s.d. of mean <i>P. yoelii</i> ANKA 18S rRNA expression in each condition (<i>n = </i>3). (C) Mice treatment by oral administration of 4 mg of genistein suspended in 200 μL water or with the same volume of water alone (control), 6 hours prior to intravenous injection of sporozoites (1×10⁴/mouse). Infection was determined 40 hours later by parasite-specific 18S rRNA qRT-PCR. <i>n = </i>3 mice per group. ★ p<0.05 (TTest relative to control group). Bar plots show one representative of 3 independent experiments. Error bars represent s.d. of mean <i>P. berghei</i> ANKA 18S rRNA expression in each condition (<i>n = </i>3). (D) Mice kept on a genistein-supplemented diet since breastfeeding or with the same diet without supplementation as a control, were injected intravenously with <i>P. berghei</i> ANKA sporozoites (1×10⁴/mouse). Infection was determined 40 hours later by parasite-specific 18S rRNA qRT-PCR. <i>n = </i>14 control group; <i>n = </i>17 genistein treated group. ♦ individual mouse, red bar represents the group average. <i>P</i> = 0.00007 (TTest relative to control group). Results are representative of 3 independent experiments. (E) Compiled data of liver infection from 5 independent experiments with mice fed on genistein-supplemented diet for a minimum of 5 weeks and injected intravenously with <i>P. berghei</i> ANKA sporozoites (1×10⁴/mouse). Infection was determined 40 hours later by parasite-specific 18S rRNA qRT-PCR. Results are expressed as frequency of mice that present a certain level of infection. Infection is expressed as the percentage of parasite specific 18S rRNA taking the average control (non-supplemented diet) as 100%. ⋄ control diet (<i>n = </i>60), ♦ 1000 ppm genistein-supplemented diet (<i>n = </i>69). <i>P</i> = 5.8×10⁻⁵ (Wilcoxon rank sum test to control group). (F) Inverse correlation between genistein levels in the sera and <i>Plasmodium</i> infection in the liver. Mice kept under genistein-supplemented diet since breastfeeding or with the same diet without supplementation, used as controls, were injected intravenously with <i>P. berghei</i> ANKA sporozoites (1×10⁴/mouse). Infection was determined 40 hours later by parasite-specific 18S rRNA qRT-PCR, sera were collected and genistein levels were determined for individual mice. Total genistein levels (ng/mL) in the sera are plotted against liver infection of individual mice. Infection is expressed as the percentage of parasite specific 18S rRNA taking the average control (non-supplemented diet) as 100%. ♦ represent the coordinates for genistein level (yy) and infection (xx) for individual mice. The red line represents the inverse correlation between the two parameters measured.</p